Marshall Wace North America’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$33.2M	Sell	359,481 -148,823	-29%	-$11.5M	0.14%	162
2021 Q2	$39.5M	Buy	508,304 +92,154	+22%	+$6.99M	0.17%	134
2021 Q1	$31M	Buy	416,150 +406,756	+4,330%	+$37.5M	0.13%	184
2020 Q4	$1.6M	Buy	+9,394	New	+$1.39M	0.01%	814
2020 Q3	–	Sell	-8,048	Closed	-$1.29M	–	1456
2020 Q2	$1.29M	Buy	+8,048	New	+$1.1M	0.01%	695
2020 Q1	–	Sell	-56,904	Closed	-$7.34M	–	1576
2019 Q4	$7.34M	Buy	56,904 +54,363	+2,139%	+$5.49M	0.04%	333
2019 Q3	$192K	Sell	2,541 -22,226	-90%	-$2.62M	﹤0.01%	965
2019 Q2	$3.76M	Sell	24,767 -197,893	-89%	-$24.1M	0.02%	421
2019 Q1	$26.5M	Buy	222,660 +50,038	+29%	+$6.43M	0.19%	118
2018 Q4	$18.8M	Buy	172,622 +15,883	+10%	+$1.99M	0.18%	108
2018 Q3	$25.3M	Sell	156,739 -123,102	-44%	-$16.8M	0.17%	127
2018 Q2	$37M	Sell	279,841 -86,392	-24%	-$8.15M	0.21%	119
2018 Q1	$27.1M	Buy	366,233 +121,512	+50%	+$8.1M	0.14%	171
2017 Q4	$13.6M	Sell	244,721 -133,626	-35%	-$7.08M	0.08%	309
2017 Q3	$17M	Buy	378,347 +365,136	+2,764%	+$14.6M	0.11%	246
2017 Q2	$449K	Buy	+13,211	New	+$430K	﹤0.01%	1104